Metabolic profiles differences of overweight patients on olanzapine, clozapine and risperidone

被引：0
作者：
Liew, Siew Fai [1 ]
Bhanu, Gupta [1 ]
Lee, Jimmy [1 ]
Chee, Kok Seng [1 ]
Neo, Li Qi [1 ]
Tang, Charmaine [1 ]
机构：
[1] Inst Mental Hlth, Singapore, Singapore
来源：
BJPSYCH OPEN | 2021年 / 7卷
关键词：
D O I：
10.1192/bjo.2021.663
中图分类号：
R749 [精神病学];
学科分类号：
100205 ;
摘要：
引用
收藏
页码：S247 / S248
页数：4
相关论文
共 50 条
  • [41] Effects of age and gender on the serum levels of clozapine, olanzapine, risperidone, and quetiapine
    Castberg, I.
    Westin, A. A.
    Skogvoll, E.
    Spigset, O.
    [J]. ACTA PSYCHIATRICA SCANDINAVICA, 2017, 136 (05) : 455 - 464
  • [42] Effect Of Risperidone And Olanzapine On The Metabolic Profile Of Drug Naive Bipolar Disorder Patients
    Gupta, Gajal
    Nagendran, S.
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2022, 64
  • [43] Metabolic syndrome in patients with schizophrenia: A comparison of Olanzapine and risperidone over 6 months
    Malhotra, Nidhi
    Kulhara, Parmanand
    Chakrabarti, Subho
    Grover, Sandeep
    [J]. INDIAN JOURNAL OF PSYCHIATRY, 2013, 55 (05) : S119 - S119
  • [44] Probabilistic classification and gambling in patients with schizophrenia receiving medication: comparison of risperidone, olanzapine, clozapine and typical antipsychotics
    Wasserman, James I.
    Barry, Rebecca J.
    Bradford, Lisa
    Delva, Nicholas J.
    Beninger, Richard J.
    [J]. PSYCHOPHARMACOLOGY, 2012, 222 (01) : 173 - 183
  • [45] Probabilistic classification and gambling in patients with schizophrenia receiving medication: comparison of risperidone, olanzapine, clozapine and typical antipsychotics
    James I. Wasserman
    Rebecca J. Barry
    Lisa Bradford
    Nicholas J. Delva
    Richard J. Beninger
    [J]. Psychopharmacology, 2012, 222 : 173 - 183
  • [46] Lack of a pharmacokinetic interaction between mirtazapine and the newer antipsychotics clozapine, risperidone and olanzapine in patients with chronic schizophrenia
    Zoccali, R
    Muscatello, MR
    La Torre, D
    Malara, G
    Canale, A
    Crucitti, D
    D'Arrigo, C
    Spina, E
    [J]. PHARMACOLOGICAL RESEARCH, 2003, 48 (04) : 411 - 414
  • [47] Effect of adjunctive lamotrigine treatment on the plasma concentrations of clozapine, risperidone and olanzapine in patients with schizophrenia or bipolar disorder
    Spina, Edoardo
    D'Arrigo, Concetta
    Migliardi, Gaetana
    Santoro, Vincenza
    Muscatello, Maria Rosaria
    Mico, Umberto
    D'Amico, Giuseppina
    Perucca, Emilio
    [J]. THERAPEUTIC DRUG MONITORING, 2006, 28 (05) : 599 - 602
  • [48] Neurocognitive effects of clozapine, olanzapine, risperidone, and haloperidol on treatment-resistant patients with schizophrenia and schizoaffective disorder
    Bilder, RM
    Goldman, RS
    Volavka, J
    Czobor, P
    Hoptman, M
    Sheitman, B
    Lindenmayer, JP
    Citrome, L
    McEvoy, J
    Kunz, M
    Chakos, M
    Lieberman, JA
    [J]. SCHIZOPHRENIA RESEARCH, 2002, 53 (03) : 194 - 194
  • [49] Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine
    Chengappa, KNR
    Pollock, BG
    Parepally, H
    Levine, J
    Kirshner, MA
    Brar, JS
    Zoretich, RA
    [J]. JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2000, 20 (03) : 311 - 316
  • [50] Anticholinergic differences among patients receiving standard clinical doses of olanzapine or clozapine
    Chengappa, KNR
    Pollock, BG
    Parepally, H
    Levine, J
    Kirshner, MA
    Brar, JS
    Zoretich, RA
    [J]. BIOLOGICAL PSYCHIATRY, 1999, 45 (08) : 13S - 13S
12345